StockSelector.com
  Research, Select, & Monitor Saturday, September 22, 2018 3:12:59 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

BOLFOUR
     Member Since:Saturday, July 12, 2003
     Recommended by 2 members.
     
 Number of Picks: 0  Average Performance: N/A


BOLFOUR's Reports
Date Company Pick Price Current Price Target Price Return
There are no reports by BOLFOUR.
Recommend BOLFOUR | Bookmark BOLFOUR

Discuss BOLFOUR & BOLFOUR's Picks
Start |  End |  Previous 25 | Next 25 |  Post New Message |  Register
View all messages    Hide off-topic    View only recommended messages   
We're sorry, but there are no messages posted in this board.

Please help get this board going by posting a message.
BOLFOUR's Recent Messages
User Topic View/Rec     Date
OSMEF  Osmetech signs 10 year OEM deal with IDEXX ; FY pretax 2,598/0    8/6/2004
OSMEF  Osmetech to launch new products 27th July 2,591/0    5/31/2004
OSMEF  Clinical Lab Expo 22-24th July at the Pennsylvania Conv 2,592/0    7/27/2003
OSMEF  RE: American Healthcare Entrepreneurs Invest in Osmetec 2,586/1    7/15/2003
OSMEF  American Healthcare Entrepreneurs Invest in Osmetech 2,604/1    7/15/2003
OSMEF  Osmetch up 7.9% in Heavy Morning Trading 2,592/0    7/14/2003
OSMEF  Osmetech says further China orders brings OPTI total sa 2,586/2    7/13/2003
2  Osmetech OSMEF / OMH.L 2,511/1    7/12/2003
8  Osmetech - OSMEF / OMH.L 2,511/0    7/12/2003
OSMEF  Comment from Andrew Onderdonk -a professor of pathology 2,581/3    7/12/2003
OSMEF  FDA approves unique e-nose technology for BV 2,521/1    7/12/2003
OSMEF  Osmetech recieves FDA approval for UTI Device. 2,530/2    7/12/2003
BOLFOUR's Estimates
There are no estimates by BOLFOUR.


Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.